TP53 and colitis: For example, p53 mutations were shown to modulate colitis-associated colon cancer in mice through a remarkably wide variety of mechanisms involving upregulation of EMT, NF-κB, or Stat3 signaling, respectively, possibly reflecting slight differences in experimental protocols that lead to distinct inflammatory conditions [95,138,143].